z-logo
Premium
Evaluating the impact of chronic obstructive pulmonary disease on in‐hospital outcomes following left ventricular assist device implantation
Author(s) -
Ebner Bertrand,
Grant Jelani K.,
Vincent Louis,
Maning Jennifer,
Olarte Neal,
Olorunfemi Odunayo,
Colombo Rosario,
Chaparro Sandra
Publication year - 2020
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.15084
Subject(s) - medicine , pulmonary disease , cardiology , ventricular assist device , intensive care medicine , heart failure
Abstract Background Chronic obstructive pulmonary disease (COPD) is a cause of ventricular dysfunction. However, in the setting of patients with heart failure undergoing left ventricular assist device (LVAD) implantation, there is a paucity of data on the association between COPD and in‐hospital outcomes. Methods and Results Retrospective cohort study based on the NIS including patients ≥18 years who underwent LVAD implantation from 2011 to 2017. Multivariate regression was used to evaluate the impact of COPD on in‐hospital outcomes. A total of 25,503 patients underwent LVAD implantation, of which 13.8% also had COPD. COPD group was older (median 62 vs. 58 years), and more males (82% vs. 76.4%, p  < .001 for both). COPD group had more hypertension, diabetes, atrial tachyarrhythmias, dyslipidemia, prior stroke, coronary artery diseases, pulmonary hypertension, and chronic kidney disease ( p  < .001 for all). No differences in strokes, infections, mechanical circulatory support, and LVAD thrombosis. There was a higher incident of inpatient acute kidney injury, major bleeding, cardiac complications, thromboembolism, and cardiac arrest in patients without COPD ( p  < .05 for all). Compared with no‐COPD group, COPD group had a lower mortality (6.2% vs. 12.4%; odds ratio, 0.59; confidence interval, 0.512–0.685; p  < .05). Conclusion Patients with COPD undergoing LVAD implantation have more comorbidities, without an associated increase mortality.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here